Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10Colorectal Neoplasms 5Ovarian Neoplasms 4Endometrial Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Prostatic Neoplasms 3Rectal Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neurofibromatosis 1 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lipodystrophy, Familial Partial 1Leukemia, Myeloid, Acute 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Hepatic Veno-Occlusive Disease 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Genetic Testing 1Biological Oxygen Demand Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lipodystrophy, Familial Partial × Genetic Testing × Clear all
NCT07412028 2026-02-17

ANDROLIPO

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting
81 enrolled

Polycystic Ovary Syndrome, Lipodystrophy, Familial Partial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡